Yu Zhang

机构：Agency for Science, Technology and Research, Shanghai Medical College of Fudan University, National University of Singapore, Chinese Academy of Medical Sciences & Peking Union Medical College, Fudan University, Beijing Botanical Garden, Inner Mongolia University of Science and Technology, South China Botanical Garden, Obstetrics and Gynecology Hospital of Fudan University, Genome Institute of Singapore · ORCID：0000-0002-3315-9427

发表论文 59 篇 · 总被引 2785 次 · h-index 21

代表论文

• Lactylation, an emerging hallmark of metabolic reprogramming: Current progress and open challenges (2022 · Frontiers in Cell and Developmental Biology · 被引 136)
• Epigenetic regulation in cancer therapy: From mechanisms to clinical advances (2024 · MedComm – Oncology · 被引 82)
• Phase-separated CCER1 coordinates the histone-to-protamine transition and male fertility (2023 · Nature Communications · 被引 21)
• LSD1 is required for euchromatic origin firing and replication timing (2022 · Signal Transduction and Targeted Therapy · 被引 19)
• Androgens drive SLC1A5-dependent metabolic reprogramming in polycystic ovary syndrome (2025 · Nature Communications · 被引 17)
• ZFP281 controls transcriptional and epigenetic changes promoting mouse pluripotent state transitions via DNMT3 and TET1 (2024 · Developmental Cell · 被引 16)